MarketCap
Facebook
X
TelegramQuarterly report 2025-Q1
added 05-30-2026
OptiNose ROCE Ratio 2011-2026 | OPTN
Annual ROCE Ratio OptiNose
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 40.43 | 26.27 | 98.71 | 305.21 | -63.83 | -70.03 | -52.19 | -21.37 | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 305.21 | -70.03 | 32.9 |
Quarterly ROCE Ratio OptiNose
| 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 40.78 | 28.41 | 30.59 | 31.59 | 35.78 | 27.64 | 42.35 | 65.42 | 107.12 | 87.65 | 112.99 | 151.02 | 258.91 | 211.21 | -52.25 | -410.51 | -850.5 | -983.63 | -1015.8 | -794.08 | -505.26 | -118.02 | -137.83 | -125.04 | -107.78 | -63.67 | -76.42 | -65.15 | -51.17 | -31.41 | -15.43 | -3.17 | -4.73 | 3.23 | 3.72 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 258.91 | -1015.8 | -119.24 |
ROCE Ratio of other stocks in the Drug manufacturers industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Endo International plc
ENDP
|
7.34 | - | - | $ 28.9 M |  Irlanda |
 |
Evoke Pharma
EVOK
|
-73.94 | - | - | $ 36.6 M |  USA |
 |
Cumberland Pharmaceuticals
CPIX
|
-5.51 | $ 5.6 | -1.23 % | $ 83.2 M | USA |
 |
HEXO Corp.
HEXO
|
-340.37 | - | 2.45 % | $ 38.1 M |  Canada |
 |
Calliditas Therapeutics AB (publ)
CALT
|
-33.39 | - | -0.1 % | $ 2.03 B |  Schweden |
 |
AcelRx Pharmaceuticals
ACRX
|
-79.15 | - | 7.5 % | $ 6.35 M | USA |
 |
DURECT Corporation
DRRX
|
-207.12 | - | - | $ 50.1 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
3101.1 | - | 0.86 % | $ 117 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
267.43 | - | - | $ 754 M | USA |
 |
Agile Therapeutics
AGRX
|
121.85 | - | 10.11 % | $ 58.2 M | USA |
 |
Alimera Sciences
ALIM
|
-4.18 | - | - | $ 142 M | USA |
 |
Cronos Group
CRON
|
-1.59 | $ 2.68 | -2.55 % | $ 1.03 B | Canada |
 |
Athenex
ATNX
|
1076.15 | - | -23.39 % | $ 1.76 M | USA |
 |
Harrow Health
HROW
|
58.18 | $ 37.64 | -0.03 % | $ 1.38 B | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
-57.41 | - | - | $ 2.06 B |  France |
 |
Catalent
CTLT
|
-20.78 | - | - | $ 11.5 B | USA |
 |
Eagle Pharmaceuticals
EGRX
|
34.66 | - | -39.89 % | $ 27.7 M | USA |
 |
Canopy Growth Corporation
CGC
|
-24.04 | $ 1.0 | -0.99 % | $ 108 M | Canada |
 |
Organogenesis Holdings
ORGO
|
14.89 | $ 2.34 | -1.68 % | $ 297 M | USA |
 |
Pacira BioSciences
PCRX
|
-9.43 | $ 22.99 | -1.58 % | $ 1.06 B | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
-84.11 | $ 1.09 | -0.91 % | $ 1.35 M | USA |
 |
Aurora Cannabis
ACB
|
0.81 | $ 3.04 | -1.3 % | $ 167 M | Canada |
 |
Solid Biosciences
SLDB
|
-90.02 | $ 7.14 | -1.11 % | $ 625 M | USA |
 |
Jupiter Wellness
JUPW
|
-116.71 | - | - | $ 33.6 M | USA |
 |
Lannett Company
LCI
|
70.21 | - | 1.15 % | $ 7.11 M | USA |
 |
OrganiGram Holdings
OGI
|
-11.66 | $ 1.06 | -1.85 % | $ 101 M | Canada |
 |
Tilray
TLRY
|
-41.31 | $ 4.98 | -2.73 % | $ 3.08 B | Canada |
 |
cbdMD
YCBD
|
-29.93 | $ 0.69 | -1.72 % | $ 2.78 M | USA |
 |
Evolus
EOLS
|
141.36 | $ 6.73 | 3.38 % | $ 434 M | USA |
 |
Sundial Growers
SNDL
|
-68.48 | $ 1.42 | -2.74 % | $ 3.37 M | Canada |
 |
Emergent BioSolutions
EBS
|
19.15 | $ 8.32 | -0.83 % | $ 445 M | USA |
 |
Veru
VERU
|
-135.01 | $ 3.0 | -7.98 % | $ 43.9 M | USA |
 |
Neoleukin Therapeutics
NLTX
|
-39.01 | - | - | $ 193 M | Canada |
 |
Assertio Holdings
ASRT
|
-22.92 | $ 23.48 | 0.04 % | $ 150 M | USA |
 |
ProPhase Labs
PRPH
|
-265.79 | - | - | $ 5.07 M | USA |
 |
Radius Health
RDUS
|
21.53 | - | - | $ 1.42 B | USA |
 |
Bausch Health Companies
BHC
|
-327.26 | $ 5.06 | -1.94 % | $ 1.88 B | Canada |
 |
PetIQ
PETQ
|
5.46 | - | 1.64 % | $ 400 M | USA |
 |
Relmada Therapeutics
RLMD
|
-68.31 | $ 6.65 | 1.99 % | $ 263 M | USA |
 |
Recro Pharma
REPH
|
-6.09 | - | -4.76 % | $ 65.3 M | USA |
 |
SCYNEXIS
SCYX
|
-32.55 | $ 4.23 | -0.35 % | $ 211 M | USA |
 |
PLx Pharma
PLXP
|
-114.37 | - | -27.8 % | $ 2.56 M | USA |
 |
Viatris
VTRS
|
-18.1 | $ 16.48 | 1.04 % | $ 19.2 B | USA |
 |
Zomedica Corp.
ZOM
|
-73.1 | - | -0.21 % | $ 98 M | USA |
 |
Zynerba Pharmaceuticals
ZYNE
|
-76.25 | - | - | $ 55.5 M | USA |
 |
Rockwell Medical
RMTI
|
-12.68 | $ 0.62 | 0.35 % | $ 22.3 M | USA |
 |
Tricida
TCDA
|
-70162.39 | - | - | $ 3.25 M | USA |
 |
China Pharma Holdings
CPHI
|
-14.24 | $ 0.71 | -6.82 % | $ 3.05 M |  China |
 |
TherapeuticsMD
TXMD
|
-16.33 | $ 2.2 | 20.88 % | $ 25.5 M | USA |